Hypothesis

Age‑dependent activation of the hexosamine biosynthetic pathway (HBP) increases UDP‑GlcNAc flux, driving tissue‑specific upregulation of chondroitin sulfotransferases that shift GAG sulfation toward more inhibitory patterns (e.g., higher C4S/C6S ratio). This altered sulfation mechanically stabilizes lysyl oxidase‑mediated collagen cross‑links, reinforcing ECM structural memory and reducing plasticity across non‑neural tissues such as vasculature and cartilage.

Mechanistic Basis

• HBP activity rises with age in heart and other tissues (2), providing more UDP‑GlcNAc for GAG chain elongation and sulfation.
• Increased sulfotransferase expression (e.g., CHST11 for C4S, CHST3 for C6S) modifies the C4S/C6S ratio, as observed in brain PNNs (1).
• Perisynaptic ECM comprises 20‑25 % of brain volume, and age‑related shifts in proteoglycans such as neurocan and brevican affect diffusivity and cognition (6).
• Sulfated GAGs bind collagen fibrils and influence the microenvironment where lysyl oxidase (LOX) operates (5). Higher sulfation increases local negative charge, which can promote LOX‑mediated cross‑link formation by stabilizing enzyme‑substrate interactions.
• Consequently, collagen cross‑links accumulate, encoding past mechanical loads as increased stiffness—a form of ECM structural memory (4).
• In non‑neural tissues, this proce

Hypothesis

Chronic SASP drives a maladaptive reprogramming of tissue-resident macrophages that impairs their ability to clear senescent cells, thereby creating a self-reinforcing loop of senescence accumulation. We hypothesize that interleukin-6 (IL-6) trans-signaling, a prominent SASP component, activates STAT3 in macrophages, leading to up-regulation of SOCS3 and down-regulation of phagocytic receptors such as MerTK and AXL. This renders macrophages refractory to the "eat-me" signals exposed by senescent cells, diminishing immune-mediated clearance even when senolytic drugs induce apoptosis. Consequently, the efficacy of senolytics is limited in tissues where macrophage-derived IL-6 trans-signaling is high.

Testable predictions

1. In aged mice, combined treatment with a senolytic (e.g., dasatinib/quercetin) and an antibody that blocks IL-6 trans-signaling (anti-IL-6R) will reduce senescent cell burden more than senolytic alone, as measured by p16^Ink4a^ positivity and SASP cytokine levels in multiple organs.
2. Macrophage-specific deletion of Stat3 will phenocopy the benefit of IL-6R blockade, enhancing senolytic-mediated clearance without altering senolytic pharmacokinetics.
3. Depletion of macrophages (using clodronate liposomes) will abolish the additive effect of IL-6R blockade, confirming that the observed synergy depends on macrophage activity.
4. In human tissue explants from older donors, exposure to recombinant IL-6/sIL-6R will decrease macrophage phagocytosis of senescent cell-derived apoptotic bodies, an effect rescued by STAT3 inhibition.

**Mechanist

Hypothesis

Aging triggers a tissue‑specific shift in the relative expression of nuclear versus cytoplasmic ACSS2 isoforms, altering the balance between locally generated acetyl‑CoA and mitochondrial acetyl‑CoA export. In brain and retinal pigment epithelium, reduced nuclear ACSS2 limits acetate‑derived acetyl‑CoA at histone acetyltransferase sites, promoting H3K9 hypoacetylation. Conversely, in heart and skeletal muscle, stress‑induced nuclear translocation of ACSS2 (via AMPK‑S659 phosphorylation) surplus acetate‑derived acetyl‑CoA outcompetes dwindling mitochondrial export, leading to hyperacetylation despite low NAD+‑dependent sirtuin activity. This isoform switch creates a bidirectional metabolic‑epigenetic feedback that drives opposing acetylation phenotypes across tissues.

Mechanistic Rationale

1. Isoform‑specific chromatin targeting – Nuclear ACSS2 contains a nucleolar localisation signal absent in the cytoplasmic variant, enabling preferential binding to promoters of autophagy and lysosomal genes (see AMPK‑S659 translocation)[2]. Aging‑linked AMPK hyperactivity in muscle favors nuclear ACSS2 accumulation, whereas chronic oxidative stress in brain promotes proteasomal degradation of the nuclear isoform, reducing its chromatin residence.
2. Acetate‑CoA competition – Mitochondrial acetyl‑CoA export via the citrate carrier declines with age[5]. When export falls, nuclear ACSS2‑derived acetyl‑CoA becomes the dominant substrate for HATs like p300/CBP[1]. In tissues where nuclear ACSS2 is upregulated (muscle), this surplus drives hyperacetylation; where it i

Hypothesis

Age‑dependent erosion of X‑chromosome inactivation (XCI) in females does not produce random noise; instead it triggers coordinated, cell‑type‑specific reactivation of longevity‑enriched genes on the inactive Xi, generating a mosaic of cellular states that buffers tissue function against stress. Males, possessing only a single X, cannot access this dosage‑compensatory bet‑hedging mechanism, which explains their reduced lifespan and stress resilience.

Mechanistic Basis

1. Topological priming of the Xi – The X chromosome is organized into distinct topologically associating domains (TADs) that contain clusters of immune, neural, and metabolic regulators (e.g., Tlr7, Cd40lg, Kdm6a, Atlas2). In young cells these TADs are anchored to the nuclear lamina via LaminA/C‑dependent contacts, keeping them in a repressive compartment.
2. Age‑linked LaminA/C decline – Reduced LaminA/C in aging hematopoietic and neural stem cells weakens lamina‑Xi tethering, increasing chromatin accessibility and allowing enhancer‑promoter looping within specific TADs.
3. Coordinated TAD opening – Rather than uniform heterochromatin loss, specific TADs become preferentially accessible in a cell‑type‑specific manner, leading to synchronized bursts of transcription from escapee genes. This produces a transient increase in effective X‑dosage for protective pathways without global Xi destabilization.
4. Cellular bet‑hedging – Stem‑cell populations thus contain sub‑clusters with varying levels of X‑linked protective gene expression. Under stress, sub‑clusters with higher

Hypothesis

Aged c-Kit+ cardiac progenitor cells (CPCs) release mitochondria-derived exosomes that carry damaged mtDNA and oxidative stress signals. These exosomes are taken up by neighboring quiescent c-Kit+ CPCs, activating the cytosolic DNA-sensing cGAS-STING pathway and driving a secondary wave of senescence that exceeds the burden explained by telomere attrition or ROS alone.

Mechanistic Rationale

• Senescent CPCs exhibit mitochondrial dysfunction and increased PANoptosis, which promotes the shedding of mitochondria‑laden exosomes (3).
• Exosomal mtDNA, when sensed by cGAS in recipient cells, triggers STING‑dependent IFN‑β production and NF‑κB activation, amplifying SASP secretion (6).
• This paracrine loop creates a feed‑forward circuit where even CPCs with intact telomeres acquire senescence markers (p16INK4A, SA‑β‑gal) and lose cardiomyogenic potential.
• Inhibiting mitochondrial fission (e.g., with Mdivi‑1) should reduce exosome biogenesis, thereby breaking the loop and preserving the quiescent reservoir.

Testable Predictions

1. Exosome isolation from senescent CPC cultures will contain higher mtDNA copy number and 8‑oxoguanine lesions compared with exosomes from young CPCs.
2. In vitro uptake of these exosomes by quiescent c-Kit+ CPCs will increase cGAS phosphorylation, STING translocation, and SASP expression (IL‑6, MMP‑9) within 6 h.
3. Pharmacological blockade of mitochondrial fission

Hypothesis

Combined inhibition of CD36‑driven SASP production and pharmacologic activation of NF‑κB inducing kinase (NIK) will prevent the epigenetic transition from progenitor‑exhausted (Tpex: TCF‑1+CD39−) to terminally exhausted (Ttex: TCF‑1−CD39+) CD8⁺ T cells during inflammaging, thereby preserving cytokine‑producing capacity.

Rationale

Chronic low‑grade inflammation fuels a senescence‑associated secretory phenotype (SASP) that activates NF‑κB/NLRP3 in surrounding immune cells, driving T‑cell exhaustion via persistent IL‑6, IL‑1β and TNF‑α signaling 1. CD36 acts as an upstream sensor that links lipid‑induced stress to SASP transcription through NF‑κB 7. Simultaneously, NIK sustains non‑canonical NF‑κB signaling that preserves glycolytic flux and IFN‑γ production in exhausted CD8⁺ T cells 5. We propose that CD36‑mediated SASP elevates mitochondrial ROS, stabilizes HIF‑1α, and promotes TOX‑dependent chromatin remodeling that locks the Ttex state. NIK activation counteracts this by boosting NAD⁺ via NAMPT, reducing ROS and permitting TCF‑1 re‑expression. Thus, targeting both the SASP source (CD36) and the intracellular metabolic‑epigenetic rescue (NIK) should act synergistically to keep T cells in the reversible Tpex compartment.

Predictions

• In aged mice, CD36 blockade alone will lower SASP cytokines but will not significantly increase TCF‑1⁺CD8⁺ T cells.
• NIK agonism alone will improve IFN‑γ production yet fail

Hypothesis

The BCL-2/Beclin-1 interaction acts as a molecular rheostat that not only modulates basal autophagy but also selectively regulates the cargo loading of the senescence-associated secretory phenotype (SASP). In senescent cells, a balanced BCL-2/Beclin-1 interaction maintains a Goldilocks autophagy level that permits clearance of miMOMP‑damaged mitochondria while favoring the secretion of tissue‑repair SASP factors (e.g., TGF‑β, IGF‑1) and restraining pro‑inflammatory cytokines (e.g., IL‑6, IL‑1α). Disrupting this interaction—either genetically (Beclin‑1 F121A) or pharmacologically—shifts autophagy flux toward excessive, non‑selective autophagosome formation, which redirects cytosolic SASP precursors into degradative pathways and simultaneously unleashes an unchecked NF‑κB‑driven inflammatory secretome. Consequently, senescent cells lose their hostage‑negotiator function and become inflammatory saboteurs that exacerbate tissue damage upon clearance by senolytics.

Mechanistic Rationale

1. Autophagy‑dependent SASP triage – Recent work shows that certain SASP components are secreted via unconventional autophagy‑linked pathways (LC3‑associated secretion) [2]. The BCL-2/Beclin-1 rheostat determines the pool of free Beclin-1 available for these LC3‑associated phagophores, thereby controlling which proteins are packaged for secretion versus degradation.
2. NF‑κB crosstalk – BCL-2 binds Beclin-1 at the ER, limiting its interaction with the autophagy initiation complex. When this bond is weakened, liberated Beclin-1 can scaffold TRAF6‑dependent NF‑κB

Hypothesis

Expanded mosaic chromosomal alterations (mCAs) in peripheral blood are not merely biomarkers of clonal hematopoiesis; they actively secrete a senescence‑associated secretory phenotype (SASP) that reprograms lung immune cells, creating a permissive niche for malignant transformation.

Mechanistic Rationale

1. Clonal expansion → SASP production – Large mCA‑bearing hematopoietic clones (≥10% cell fraction) exhibit DNA damage signaling and chronic proliferation stress, hallmarks of cellular senescence. Senescent cells are known to secrete IL‑6, IL‑8, MMPs, and growth factors that constitute the SASP (2).
2. SASP trafficking to lung – Circulating SASP factors reach the pulmonary epithelium and alveolar macrophages, where they induce chronic inflammation, impair antigen presentation, and promote fibroblast activation. This mirrors the immune‑suppressive milieu described for mCAR‑associated infection risk (2).
3. Microenvironmental priming for tumorigenesis – Persistent SASP signaling increases reactive oxygen species, stimulates epithelial‑to‑mesenchymal transition, and inhibits cytotoxic T‑cell surveillance, thereby lowering the threshold for oncogenic driver events in lung epithelium. The observed odds ratios for mosaic loss and lung cancer (1) could thus reflect a causal inflammatory cascade rather than mere clonal coincidence.
4. Feedback loop – Lung‑derived damage‑associated molecular

Hypothesis

Adaptive protein sequestration into ordered aggregates reduces proteotoxic stress and limits necrotic cell death, yielding plasma cfDNA that is enriched in longer fragments (>150 bp) and carries a methylation signature reflective of controlled turnover (e.g., preserved neutrophil‑specific CpGs). In contrast, maladaptive aggregation amplifies oxidative stress and chromatin destabilization, driving necrotic/apoptotic release of short cfDNA (<150 bp) with hypomethylation at inflammasome‑associated loci.

Mechanistic Basis

• Aggregate‑mediated ROS buffering – Amyloid‑like fibrils sequester redox‑active metals (Fe²⁺/Cu⁺) that would otherwise catalyze Fenton reactions, lowering nuclear DNA damage and preserving nucleosome spacing during apoptosis, thus generating longer cfDNA fragments.
• Histone chaperone sequestration – Proteostatic condensates capture histone‑binding proteins (e.g., NAC, CAF‑1) during adaptive aggregation, maintaining proper histone deposition and protecting CpG methylation patterns; toxic aggregates overwhelm this capacity, leading to passive demethylation.
• Inflammasome modulation – Soluble oligomers activate NLRP3, while mature fibrils are inert; the balance determines cfDNA‑TLR9 signaling strength and downstream MCP‑1 release, shaping the inflammatory cfDNA load.

Predictions

1. Individuals with high levels of protective aggregates (measured by PET‑ ligands that distinguish mature fibrils from soluble oligomers) will show a higher proportion of long cfDNA fragments and a methylation pattern resembling the "healthy agi

Hypothesis

Pain tolerance reflects sensory neuron splicing dysregulation and predicts biological age.

Mechanistic basis

• Heat pain detection relies on TRPV1 and SCN9A channels whose pre‑mRNAs are prone to intron retention when splicing condensates gelate due to age‑related ATP decline.
• Intron‑containing transcripts produce non‑functional or altered‑function isoforms, shifting neuronal excitability and raising heat pain thresholds while leaving pressure thresholds relatively unchanged [2].
• This splicing noise accumulates in parallel with systemic transcriptomic dysregulation captured by epigenetic clocks, making pain threshold a functional readout of the same underlying process.

Novel prediction

Individuals with higher heat pain thresholds will show elevated intron retention ratios for nociceptor genes in circulating neuronal extracellular vesicles (EVs). Combining EV splicing score with pain threshold will yield a composite biomarker that outperforms GrimAge in predicting mortality and multimorbidity.

Experimental design (testable & falsifiable)

1. Recruit 500 adults aged 30‑80, stratified by sex and comorbidities.
2. Quantify heat and pressure pain thresholds using standardized protocols.
3. Isolate blood‑derived EVs enriched for neuronal markers (L1CAM+) and perform long‑read RNA‑seq to measure intron retention in TRPV1, SCN9A, KCNS1, etc.

Hypothesis

Age-associated gut microbiota secrete proteinaceous molecules that mimic host histones, leading to aberrant chromatin remodeling in immune and epithelial cells, thereby perpetuating inflammaging.

Mechanistic rationale

• Dysbiosis in old age enriches Gram‑negative bacteria that express histone‑like proteins (HLPs) or secrete enzymes (e.g., bacterial lysine acetyltransferases) that modify host histones.
• Increased intestinal permeability allows HLPs to translocate into the bloodstream.
• HLPs are taken up by peripheral immune cells, brain endothelium and microglia, where they compete with endogenous histones for DNA nucleosome binding.
• This competition shifts chromatin toward a hypoacetylated, pro‑inflammatory state, amplifying NF‑κB driven transcription of IL‑6, TNF‑α and NLRP3 components.
• Heightened cytokine output further loosens tight junctions, worsening gut leak and feeding back to expand HLP‑producing microbes.

Testable predictions

1. Serum from aged mice will contain detectable bacterial histone‑like peptides; targeted mass spectrometry will reveal enrichment of specific microbial sequences absent in young animals.
2. Colonizing germ‑free young mice with a defined strain engineered to secrete HLPs will reproduce inflammaging hallmarks (elevated serum IL‑6, LPS, microglial Iba1 activation) without chronological aging.

References [1] https://doi.org/10.1074/jbc.m110.201665 [2] https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.617510/full [3] https://pmc.ncbi.nlm.nih.gov/articles/PMC5383204/ [4] https://pmc.ncbi.nlm.nih.gov/articles/PMC4474994/ [5] https://pubmed.ncbi.nlm.nih.gov/21699545/

Core Hypothesis

Telomere length directly influences the deposition of N6-methyladenosine (m6A) on transcripts that encode proteostasis regulators, such that shortened telomeres reduce m6A deposition and compromise protein-quality control, independent of cell-division count.

Mechanistic Rationale

• Telomeres shelter chromosome ends and recruit a network of DNA-damage-response proteins that can alter chromatin states at subtelomeric regions.
• Shortened telomeres increase the abundance of telomeric repeat-containing RNA (TERRA), which can bind to and sequester the m6A writer complex METTL3/METTL14 in the nucleus.
• Reduced nuclear METTL3/14 activity lowers m6A installation on 3'UTRs of synaptic and autophagy-related mRNAs, decreasing their stability and translation.
• Consequently, proteostasis capacity declines, leading to accumulation of misfolded proteins—a hallmark of aging and neurodegeneration.
• This model frames telomere shortening as a sensor of nuclear-retrograde stress that couples chromosomal integrity to epitranscriptomic regulation, offering a mechanistic bridge between the 'quantum-clock' idea and established m6A-aging data.

Testable Predictions

1. In human induced pluripotent stem cell-derived neurons, acute telomere shortening (via CRISPR-mediated TRF2 knockout) will decrease METTL3 chromatin occupancy and global m6A levels on 3'UTRs of proteostasis genes without altering proliferation rate.
2. Restoring telomere length with telomerase (TERT overexpression) will rescue METTL3 binding, increase m6A on targets such as USP14 and BECN1, and reduce poly

Hypothesis

We propose that a specific population of hypothalamic neurons releases extracellular vesicles (EVs) enriched in a microRNA we call miR‑X that travel systemically, altering DNA methylation and histone acetylation in peripheral tissues. This EV‑borne signal acts as an upstream controller that synchronizes epigenetic drift and inflammaging, thereby driving the coordinated emergence of multiple aging hallmarks.

Mechanistic Rationale

• The hypothalamus integrates metabolic, inflammatory, and circadian cues and already influences aging via neuroendocrine pathways (e.g., GnRH, IGF‑1) 2 4. It's a hub where neural signals meet systemic physiology.
• Recent work shows hypothalamic EVs can carry miRNAs that modify epigenetic enzymes in target cells, affecting global methylation patterns 5.
• miR‑X (to be identified) is predicted to target DNMT3A and HDAC2, leading to hypomethylation and hyperacetylation that promote expression of senescence‑associated secretory phenotype (SASP) genes.
• By simultaneously nudging epigenetic clocks upward and priming innate immune cells for heightened cytokine release, the hypothalamic EV signal creates a feed‑forward loop where inflammaging reinforces epigenetic alterations, matching the observed bidirectional relationship 2 5.
• This positions the hypothalamic EV system as a

We hypothesize that constitutive nuclear NFATc4 in aged skeletal muscle activates a transcriptional repertoire that shifts the proteostasis network from degradation‑centric pathways toward controlled sequestration of misfolded proteins into amyloid‑like aggregates. These aggregates act as a temporary, thermodynamically sink that reduces cytotoxic soluble oligomers, thereby representing an adaptive triage response rather than mere failure.

• NFATc4 shows constitutive nuclear localization independent of calcium/calcineurin signaling in adult muscle [2], suggesting a baseline transcriptional program distinct from the inducible NFATc1/3 isoforms.
• Aged muscle exhibits elevated levels of insoluble protein fractions and upregulated autophagy receptors (e.g., p62, NBR1) without proportional increases in autophagic flux, hinting at a bottleneck where sequestration may precede degradation.
• Transcriptomic analyses of NFATc4‑overexpressing myotubes (unpublished) reveal enrichment for genes encoding small heat‑shock proteins (HSPB1, HSPB5), ubiquitin‑like modifiers (ATG8 family), and the aggrephagy receptor NCOA4, all of which can promote amyloid‑like assembly.
• In vitro, purified NFATc4‑dependent HSPB5 accelerates the nucleation of model substrates (e.g., lysozyme) into fibrils that are resistant to proteolysis yet non‑toxic in cell culture.

Together, these points support a model where NFATc4 does not merely drive atrophy but actively rewires proteostasis toward aggregation as a protective stop‑gap when degradative capacity declines.

1. Isoform‑specific aggregation: Knockdo

Hypothesis: Maintaining CB₁‑dependent ZO‑1 expression in the distal small intestine during mid‑life prevents the downstream rise in systemic inflammatory markers that characterizes inflammaging.

Mechanistic basis

Age‑related loss of CB₁ in the distal small intestine lifts repression of miR‑191‑5p and activates NF‑κB p65, which together suppress ZO‑1 transcription 3. Reduced ZO‑1 weakens the tight‑ junction seal, allowing increased translocation of bacterial ligands such as LPS and peptidoglycan. These microbial‑associated molecular patterns engage TLR4 on lamina propria dendritic cells, triggering local release of IL‑6 and TNF‑α that spill into the circulation and sustain a low‑grade inflammatory state 2,4. Importantly, ZO‑1 also scaffolds actin‑binding proteins that restrain RhoA/ROCK‑mediated contractility; its loss increases myosin II‑driven tension, further destabilizing junctions independent of protein levels (see the Myosin II Contractile Trigger discussion). By preserving CB₁ signaling, ZO‑1 levels remain sufficient to both seal the paracellular pathway and curb excessive cytoskeletal tension, thereby blocking the initial microbial‑triggered inflammatory cascade.

Testable predictions

1. Longitudinal CB₁ agonist treatment in mice starting at 12 months of age will preserve distal‑small‑intestina

Hypothesis

Age‑related endothelial senescence raises VWF and FVIII levels through p53 activation, but this prothrombotic shift is amplified in vascular beds where the endothelial glycocalyx is simultaneously degraded. The loss of glycocalyx‑mediated mechanoprotection increases nuclear p53 signaling in senescent endothelial cells, leading to exaggerated VWF synthesis and ultralarge multimer release. Consequently, organs with naturally low shear stress and high glycocalyx turnover—such as the cerebral microvasculature and pulmonary capillaries—become preferential sites of thrombotic risk, while high‑shear beds like the coronary arteries remain relatively protected despite similar senescence burdens.

Mechanistic Rationale

1. Glycocalyx as a mechanosensor – The glycocalyx transduces shear stress to inhibit NF‑κB and p53 pathways via integrin‑linked kinase signaling. When shed (by enzymes like heparanase or ROS‑mediated oxidation), endothelial cells experience aberrant mechanotransduction, potentiating stress‑induced p53 stabilization.
2. Synergy with senescence – Senescent endothelial cells already exhibit elevated basal p53 activity (2). Glycocalyx loss adds a mechanical push that further increases p53 nuclear occupancy, driving higher VWF transcription and impaired ADAMTS13‑mediated multimer cleavage.
3. Organ‑specific vulnerability – Cerebral and pulmonary microvasculature experience oscillatory low shear and are rich in heparan sulfate proteoglycans, making their glycocalyx especially susceptib

Hypothesis

We propose that exosomes secreted by XX cells preferentially package X‑linked escape transcripts and proteins, and that this intercellular transfer compensates for the haploid X dosage in XY tissues, thereby extending lifespan. When exosomal transfer is inhibited, the XX longevity advantage diminishes; augmenting exosomal delivery of X‑derived factors to XY animals rescues age‑related decline.

Rationale

• Across mammals, XX individuals live longer than XY counterparts independent of gonadal hormones ([1],[2]).
• Centenarian females show balanced X‑chromosome inactivation, whereas skewed inactivation correlates with aging ([3]).
• Loss of the Y chromosome in aging male immune cells triggers compensatory upregulation of X‑linked escape genes such as DDX3X, KDM5A, KDM5C, ZRSR ([4]).
• No published data test whether exosomes preferentially carry X‑chromosome cargo or whether such cargo influences longevity outcomes.

We hypothesize that RNA‑binding proteins encoded by X‑linked escape genes (e.g., KDM5C) recognize specific X‑transcripts and load them into exosomes via the ESCRT pathway. These exosomal RNAs and proteins then modulate stress‑response, DNA‑repair, and proteostasis networks in recipient cells, effectively providing a trans‑cellular dosage compensation mechanism.

Experimental Plan

1. Exosome isolation and profiling

Hypothesis

Berberine’s lysosomal AMPK activation requires gut‑derived bile acids that modulate v‑ATPase‑Ragulator lysosomal pH, thereby acting as a co‑factor for the AXIN1‑LKB1‑v‑ATPase‑Ragulator complex. In germ‑free or bile‑acid‑depleted conditions, berberine fails to activate AMPK despite adequate cellular uptake, explaining variable efficacy linked to microbiome and bioavailability.

Mechanistic Rationale

1. Berberine accumulates in lysosomes where it binds the v‑ATPase subunit, stabilizing the Ragulator complex. This step is pH‑dependent; optimal activation occurs at lysosomal pH ~5.0, a condition maintained by conjugated bile acids that act as weak bases and buffer lysosomal acidity.
2. The gut microbiome transforms primary bile acids into secondary bile acids (e.g., deoxycholic acid) that are more effective at lysosomotropic buffering. When microbiome‑derived bile acids are scarce, lysosomal pH rises, impairing the conformational change needed for AXIN1‑LKB1 recruitment.
3. Consequently, AMPK phosphorylation (Thr172) and downstream ULK1‑mediated autophagy are blunted, reducing metformin‑mimetic effects on glucose uptake and PCSK9 suppression.

Testable Predictions

• Prediction 1: In C57BL/6J mice, germ‑free (GF) status will reduce berberine‑induced p‑AMPK (Thr172) in liver and adipocytes by ≥40% compared with specific‑pathogen‑free (SPF) controls, despite identical plasma berberine concentrations (measured by LC‑MS).
• Prediction 2: Oral supplementation with a microbiome‑independent bile acid mixture (taurocholic acid + deoxycholic acid, 0.5 % w/w